Benefits of µCor in Ambulatory Decompensated Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 257 participants.

Also called NCT03476187

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 257 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03476187
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03476187. Allocation not applicable; no masking; primary purpose diagnostic. Start 2018-08-17 (actual); primary completion 2024-01-08 (actual). Results posted on 2024-08-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Benefits of µCor in Ambulatory Decompensated Heart Failure
Acronym
BMADHF
Condition
Heart Failure
Intervention (Device)
µCor
Lead sponsor
Zoll Medical Corporation (class: industry)

Record details

Record id
cardio:ct-nct03476187
Content hash
d1147d28ef3a82e35e5bae4276a66b621192da9df8bdda163073156d9a3619c4